AzTrials
AzTrials

Colonic PolypNCT03567746

Underwater EMR vs. Conventional EMR for Large Non-pedunculated Colonic Polyp

A study testing Underwater EMR and Conventional EMR in people with Colonic Polyp, run by Parc de Salut Mar at 2 sites in Spain.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

To analyse the efficacy and safety of two standard methods of endoscopic mucosal resection (EMR) for large non-pedunculated colorectal polyps, the investigators will compare submucosal injection-assisted endoscopic mucosal resection (SEMR) versus underwater endoscopic mucosal resection, without submucosal injection… Read more about this study

Who is it for?
Ages 18 to 85 years
Conditions the study is for
Colonic Polyp
What is being tested?
Underwater EMR and Conventional EMR
Could I receive a placebo?
No, everyone receives an active treatment
How many people
356 participants
Where
2 sitesSpain
Study dates
4 Jun 2018to 30 Dec 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 85 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Consecutive patients aged >18 years, diagnosed with a large (>=20 mm) non-pedunculated colonic polyp, who consent to endoscopic mucosal resection of the polyp and willing to participate in this study.

Who cannot join

  • Polyps showing signs of deep submucosal invasion
  • Inflamatory bowel disease with signs of activity
  • Known or suspected pregnancy
  • Patients unable or unwilling to provide informed consent

Trial locations and contacts

2 sites in 1 country.

Joaquin Rodriguez, MD PhD contact

926278000 ext. 79114

joakinrodriguez@gmail.com

Marco A Alvarez-Gonzalez, MD PhD contact

marcoalgo@gmail.com

Spain2 sites, 2 recruiting
  • Hospital del Mar. Parc de Salut Mar

    Barcelona, 08003

    Marco A Alvarez-Gonzalez, MD PhD, 0034 932483000, marcoalgo@gmail.com

    Recruiting
  • Hospital General Universitario de Ciudad Real

    Ciudad Real, 13005

    Joaquin Rodriguez Sanchez, MD PhD, joakinrodriguez@gmail.com

    Recruiting

Other trials in Spain

About this study

Official title: Efficacy and Safety of Underwater Endoscopic Mucosal Resection Versus Conventional Endoscopic Mucosal Resection for the Treatment of Large Non-pedunculated Colonic Lesions. Multicentric Randomized Controlled Trial

To analyse the efficacy and safety of two standard methods of endoscopic mucosal resection (EMR) for large non-pedunculated colorectal polyps, the investigators will compare submucosal injection-assisted endoscopic mucosal resection (SEMR) versus underwater endoscopic mucosal resection, without submucosal injection (UEMR).

Read the detailed description

Underwater endoscopic mucosal resection (UEMR) emerges as a variant of traditional resection, in which a submucosal cushion formation is not necessary. This technique was described in 2012 by Kenneth Binmoeller based on the physical floating effect of colonic mucous membrane by filling the colonic lumen using water instead of air. This "floating effect" conditions the natural separation of the colonic wall layers, allowing the distension of the submucosal space without the need to inject substances into it. On the other hand, performing resection in liquid medium conditions could drive the benefit of heat dissipation caused by the current, which would reduces thermal damage caused to the tissues.

Conditions
Colonic Polyp
Being tested
Underwater EMR, Conventional EMR
Keywords
Colonic Polyp, Endoscopic mucosal resection
Medical subject headings
Colonic Polyps

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Underwater EMRProcedure or surgery

    Polypectomy is performed under full water emersion avoiding the use of submucosal injection.

  • Conventional EMRProcedure or surgery

    It will be performed in a 2-step procedure. First the formation of a submucosal injection underneath the polyp to create a submucosal safety cushion. Then EMR is performed with a polipectomy snare.

Study groups in NCT03567746
Study groupRoleWhat they receive
Underwater EMRExperimentalThe patients randomized in this arm will be treated by endoscopic resection assisted by the filling of the colonic lumen using water instead of air and avoiding the formation of a submucosal cushion
Receives: Procedure: Underwater EMR
Conventional EMRActive comparatorThe patients randomized in this arm will be treated by endoscopic resection following the traditional technique. It means, by assistance of selective submucosal saline injection to create a submucosal cushion below the polyp.
Receives: Procedure: Conventional EMR

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Lesion recurrence rate

    Presence of polyp tissue at the same site as the original lesion (adenoma or sessile serrated polyp)

    Measured: 1 year

Secondary outcomes (7)
  1. Technical success rate

    Complete removal of polypoid tissue during the procedure

    Measured: 1 hour

  2. Incidence of Treatment-Emergent Adverse Events

    Incidence of Treatment-Emergent Adverse Events (delated hemorrhage, perforation, hospital admission)

    Measured: 1 year

  3. En bloc Resection rate

    Rate of endoscopic mucosal resection in one piece during the procedure

    Measured: 1 hour

  4. Procedure time

    Time in minutes for the endoscopic mucosal resection

    Measured: 1 hour

  5. Number of fragments

    Number of fragments of the endoscopic mucosal resection

    Measured: 1 hour

  6. Lesion size

    Size of the lesion in millimeters

    Measured: 1 hour

  7. Thermal artecfacts

    Measured: 1 hour

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Jun 2018
  2. Study start4 Jun 2018
  3. Primary completion30 Dec 2019 (estimated)
  4. Study completion30 Dec 2019 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
356 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03567746
Sponsor's protocol ID
UEMR
Status last verified
Jul 2019
First submitted
13 Jun 2018
Last updated
25 Jul 2019
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Rodriguez Sanchez J, Alvarez-Gonzalez MA, Pellise M, Coto-Ugarte D, Uchima H, Aranda-Hernandez J, Santiago Garcia J, Marin-Gabriel JC, Riu Pons F, Nogales O, Carreno Macian R, Herreros-de-Tejada A, Hernandez L, Patron GO, Rodriguez-Tellez M, Redondo-Cerezo E, Sanchez Alonso M, Daca M, Valdivielso-Cortazar E, Alvarez Delgado A, Enguita M, Montori S, Albeniz E. Underwater versus conventional EMR of large nonpedunculated colorectal lesions: a multicenter randomized controlled trial. Gastrointest Endosc. 2023 May;97(5):941-951.e2. doi: 10.1016/j.gie.2022.12.013. Epub 2022 Dec 23.

    PubMed 36572129

Questions about this trial

What is this clinical trial studying?

A study testing Underwater EMR and Conventional EMR in people with Colonic Polyp, run by Parc de Salut Mar at 2 sites in Spain.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 25 Jul 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Joaquin Rodriguez, MD PhD (926278000 ext. 79114, joakinrodriguez@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Lesion recurrence rate (time frame: 1 year). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03567746, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Jul 2019; AzTrials last refreshed its copy on 6 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in